CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma. (Q53048153)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

0 references

1 reference

based on heuristic

inferred from title

author name string

Casey E Gooden

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Patricia Jones

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Ruth Bates

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Wendy M Shallenberger

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Urvashi Surti

5

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Steven H Swerdlow

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Christine G Roth

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

publication date

27 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Cytometry Part B: Clinical Cytometry

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

94

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

129-135

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

How I treat CLL up front

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Prognostic markers in chronic lymphocytic leukemia: a comprehensive review

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Improved ZAP‐70 assay using two clones, multiple methods of analysis and clinical correlation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Combined normal donor and CLL: Single tube ZAP-70 analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Methodological comparison of two anti‐ZAP‐70 antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Trisomy 12 CLLs progress through NOTCH1 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

NOTCH1 mutations in CLL associated with trisomy 12.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutatedIGHVstatus

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

21 January 2018

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: Results of the multicenter O-CLL1-GISL study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.21384

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CYTO.B.21384

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/27221715

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53048153&oldid=1492867934"